The Gustave Roussy immune score as a novel biomarker for predicting survival in patients with isocitrate dehydrogenase wild-type glioblastoma treated with the Stupp protocol
GRIm-Score is a simple and reliable prognostic indicator in IDH-wt glioblastoma. Its routine use may improve risk stratification and inform therapeutic decisions. Further prospective multicenter validation is warranted.
Authors
- Mustafa Yıldız (ORCID: https://orcid.org/0000-0001-7832-5989)
- Neslihan Atabek (ORCID: https://orcid.org/0000-0002-2499-1078)
- Ece Ulukal Karancı (ORCID: https://orcid.org/0000-0002-0930-1016)
- Rıdvan Yavuz (ORCID: https://orcid.org/0000-0002-9528-2148)
- Kamuran Yuceer (ORCID: https://orcid.org/0000-0002-7721-5646)
- Erkan Kayıkçıoğlu (ORCID: https://orcid.org/0000-0002-7401-5446)
- Asım Armağan Aydın (ORCID: https://orcid.org/0000-0001-8749-9825)
- Ahmet Ünlü (ORCID: https://orcid.org/0000-0001-6654-3815)
- Gizem Zorlu Görgülügil (ORCID: https://orcid.org/0000-0002-0773-7000)
- Mehmet Acun (ORCID: https://orcid.org/0000-0003-1649-348X)
- Banu Öztürk (ORCID: https://orcid.org/0000-0003-0290-8787)
Institutions
- Antalya Bilim University (TR)
- Antalya Eğitim ve Araştırma Hastanesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Liv Hospital (TR)
- Antalya IVF (TR)
- University of Health Sciences Antigua (AG)
- Erciyes University (TR)
Publication Details
- Journal
- Expert Review of Anticancer Therapy
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1080/14737140.2025.2555467
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00